Navigation Links
C. Difficile Tox A/B II

ProductsC. Difficile Tox A/B II
Company Inverness Medical Innovations
Item C. Difficile Tox A/B II
Features 
  • Detects both A+ and A-/B+ strains
  • Assay is performed within 30 minutes
  • No gray zone eliminates equivocal results
  • Excellent correlation to tissue culture
  • Results can be interpreted using manual or automated methods
Description The C. Difficile Tox A/B II is a second-generation rapid ELISA for the detection of Clostridium difficile toxins A and B in fecal specimens. The test utilizes highly specific antibodies and produces highly sensitive results detecting not only the more common toxin A+ samples, but also samples that are toxin A-/B+. It's easy to perform, produces no indeterminates and provides results in one hour or less. The relative sensitivity and specificity of the test are 92.2% and 100%, respectively, when compared to tissue culture.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Clostridium Difficile Toxin A RAPYDTEST®
2. Bartels® C. Difficile Toxin A Antigen EIA with Controls
3. Difficile Tox A/B II with Fecal-Quik-Prep
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Rev. Angled 9.5 overall length 4.5 handle 240 mm....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Medicine Products:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... Columbus, OH (PRWEB) , ... December 05, 2016 ... ... novel engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy ... usability in various healthcare settings. , Over the last 60 years, studies ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Findings from ... safety of CTL019, an investigational chimeric antigen receptor ... pediatric and young adult patients with B-cell acute ... an oral session at the 58th American Society ... 3, 4:00-5:30 p.m.). The global Phase II study ...
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical Laboratories, ... de la Compañía, el INSTI HIV Self Test , a los miembros ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: